A Critical Review of Gastric Retentive Controlled Drug Delivery

REFERENCES

• Moës A.J. Gastroretentive dosage forms. Crit. Rev. Ther. Drug Carrier Syst. 1993; 10: 143–195
   PubMed Web of Science ®Google Scholar
• Deshpande A.A., Rhodes C.T., Shah N.H., Malick A.W. Controlled-release drug delivery systems for prolonged gastric residence: an overview. Drug Dev. Ind. Pharm. 1996; 22(6)531–539
   Web of Science ®Google Scholar
• Hwang S.-J., Park H., Park K. Gastric retentive drug-delivery systems. Crit. Rev. Ther. Drug Carrier Syst. 1998; 15(3)243–284
   PubMed Web of Science ®Google Scholar
• Singh B.N., Kim K.H. Floating drug delivery systems: An approach to oral controlled drug delivery via gastric retention. J. Control. Release 2000; 63: 235–259
   PubMed Web of Science ®Google Scholar
• Fell J.T., Whitehead L., Collett J.H. Prolonged gastric retention using floating dosage forms. Pharm. Tech. March, 2000, 82, 84, 86, 88, 90
   Google Scholar
• Soppimath K.S., Kulkarni A.R., Rudzinski W.E., Aminabhavi T.M. Microspheres as floating drug-delivery systems to increase gastric retention of drugs. Drug Met. Rev. 2001; 33: 149–160
   PubMed Web of Science ®Google Scholar
• Gutierrez-Rocca J., Omidian H., Shah K. Progress in gastroretentive drug delivery systems. Business Briefing: Pharmatech. 2003; 152–156
   Google Scholar
• Hou S.Y.E., Cowles V.E., Berner B. Gastric retentive dosage forms: a review. Crit. Rev. Ther. Drug Carrier Syst. 2003; 20: 461–497
   Web of Science ®Google Scholar
• Klausner E.A., Lavy E., Friedman M., Hoffman A. Expandable gastroretentive dosage forms. J. Control. Release 2003; 90(2)143–162
   PubMed Web of Science ®Google Scholar
• Moës A.J. Gastric retention systems for oral drug delivery. Business Briefing: Pharmatech. 2003; 157–159
   Google Scholar
• Talukder R., Fasshihi R. Gastroretentive delivery systems: A mini review. Drug Dev. Ind. Pharm. 2004; 30: 1019–1028
   PubMed Web of Science ®Google Scholar
• Hoffman A., Stepensky D., Lavy E., Eyal S., Klausner E., Friedman M. Pharmacokinetic and pharmacodynamic aspects of gastroretentive dosage forms. Int. J. Pharm. 2004; 277(1–2)141–153
   PubMed Web of Science ®Google Scholar
• Chowdary K.P.R., Rao Y.S. Mucoadhesive microspheres and microcapsules: Current status. Ind. J. Pharm. Sci. 2005; 67: 141–150
   Google Scholar
• Rocca J.G., Omidian H., Shah K.U. Commercial status of gastric retention technologies. Drug Del. Tech. 2005; 50–58
   Google Scholar
• Bardonnet P.L., Faivre V., Pugh W.J., Piffaretti J.C., Falson F. Gastroretentive dosage forms: Overview and special case of Helicobacter pylori. J. Control. Release 2006; 111(1–2)1–18
   PubMed Web of Science ®Google Scholar
• Streubel A., Siepmann J., Bodmeier R. Gastroretentive drug delivery systems. Expert Opin. Drug Deliv. 2006; 3(2)217–233
   PubMedGoogle Scholar
• Fix J.A., Cargill R., Engle K. Controlled gastric emptying. III. Gastric residence time of a nondisintegrating geometric shape in human volunteers. Pharm. Res. 1993; 10: 1087–1089
   PubMed Web of Science ®Google Scholar
• Coupe A.J., Davis S.S., Evans D.F., Wilding I.R. Correlation of the gastric emptying of nondisintegrating tablets with gastrointestinal motility. Pharm. Res. 1991; 8(10)1281–1285
   PubMed Web of Science ®Google Scholar
• Itoh T., Higuchi T., Gardner C.R., Caldwell L. Effect of particle size and food on gastric residence time of non-disintegrating solids in beagle dogs. J. Pharm. Pharmacol. 1986; 38(11)801–806
   PubMed Web of Science ®Google Scholar
• Kaniwa N., Aoyagi N., Ogata H., Ejima A. Gastric emptying rates of drug preparations. I. Effects of size of dosage forms, food and species on gastric emptying rates. J. Pharm.-Dyn. 1988; 11(8)563–570
   Google Scholar
• 21. Nause, R., Li, F., Sagawa, K. Modeling and prediction of upper GI transit times for non-disintegrating oral dosage forms, Manuscript in preparation.
   Google Scholar
• Davis S.S., Hardy J.G., Fara J.W. Transit of pharmaceutical dosage forms through the small intestine. Gut 1986; 27(8)886–892
   PubMed Web of Science ®Google Scholar
• Ewe K., Press A.G., Bollen S., Schuhn I. Gastric emptying of indigestigle tablets in relation to composition and time of ingestion of meals studied by metal detector. Dig. Dis. Sci. 1991; 36(2)146–152
   PubMed Web of Science ®Google Scholar
• Steed K.P., Hooper G., Monti N., Strolin Benedetti M., Fornasini G., Wilding I.R. The use of pharmacoscintigraphy to focus the development strategy for a novel 5-ASA colon targeting system (“TIME CLOCK” system). J. Control. Release 1997; 49(2,3)115–122
   Web of Science ®Google Scholar
• Khosla R., Davis S.S. The effect of polycarbophil on the gastric emptying of pellets. J. Pharm. Pharmacol. 1987; 39: 47–49
   PubMed Web of Science ®Google Scholar
• Harris D., Fell J.T., Sharma H.L., Taylor D.C. Gastrointestinal transit of potential bioadhesive formulations in man: A scintigraphic study. J. Control. Release 1990; 12: 45–53
   Web of Science ®Google Scholar
• Jackson S.J., Bush D., Perkins A.C. Comparative scintigraphic assessment of the intragastric distribution and residence of cholestyramine, Carbopol 934P and sucralfate. Int. J. Pharm. 2001; 212: 55–62
   PubMed Web of Science ®Google Scholar
• Säkkinen M., Tuononen T., Jürjenson H., Veski P., Marvola M. Evaluation of microcrystalline chitosans for gastro-retentive drug delivery. Eur. J. Pharm. Sci. 2003; 19: 345–353
   PubMed Web of Science ®Google Scholar
• Säkkinen M., Marvola J., Kanerva H., Lindevall K., Lipponen M., Kekki T., Ahonen A., Marvola M. Gamma scintigraphic evaluation of the fate of microcrystalline chitosan granules in human stomach. Eur. J. Pharm. Biopharm. 2004; 57: 133–143
   PubMed Web of Science ®Google Scholar
• Ch'ng H. S., Park H., Kelly P., Robinson J.R. Bioadhesive polymers as platforms for oral controlled drug delivery. II. Synthesis and evaluation of some swelling, water-insoluble bioadhesive polymers. J. Pharm. Sci. 1985; 74(4)399–405
   PubMed Web of Science ®Google Scholar
• Lehr C.M., Bouwstra J.A., Schacht E.H., Junginger H.E. In vitro evaluation of mucoadhesive properties of chitosan and some other natural polymers. Int. J. Pharm. 1992; 78: 43–48
   Web of Science ®Google Scholar
• He P., Davis S.S., Illum L. In vitro evaluation of the mucoadhesive properties of chitosan microspheres. Int. J. Pharm. 1998; 166: 75–88
   Web of Science ®Google Scholar
• Gåserød O., Jolliffe A.G., Hampson F.C., Dettmar P.W., Skjåk-Braek G. The enhancement of the bioadhesive properties of calcium alginate gel beads by coating with chitosan. Int. J. Pharm. 1998; 175: 237–246
   Web of Science ®Google Scholar
• Slovin E.M., Robinson J.R. Bioadhesives in ocular drug delivery. Biopharm. Ocul. Drug Deliv. 1993; 145–157
   Google Scholar
• Signorin J., Aguinaldo E.R., Reilly W.J. Nasal mucoadhesive characteristics of co-processed MCC CMC-Avicel RC-591. Proc. Intern. Symp. Control. Release Bioact. Mat. 1998; 25: 758–759
   Google Scholar
• Ugwoke M.I., Exaud S., Van Den Mooter G., Verbeke N., Kinget R. Bioavailability of apomorphine following intranasal administration of mucoadhesive drug delivery systems in rabbits. Eur. J. Pharm. Sci. 1999; 9: 213–219
   PubMed Web of Science ®Google Scholar
• Ugwoke M.I., Verbeke N., Kinget R. The biopharmaceutical aspects of nasal mucoadhesive drug delivery. J. Pharm. Pharmacol. 2001; 53: 3–22
   PubMed Web of Science ®Google Scholar
• Jain S.K., Chourasia M.K., Jain A.K., Jain R.K., Shrivastava A.K. Development and characterization of mucoadhesive microspheres bearing salbutamol for nasal delivery. Drug Deliv. 2004; 11(2)113–122
   PubMed Web of Science ®Google Scholar
• Edsman K., Haegerstroem H. Pharmaceutical applications of mucoadhesion for the non-oral routes. J. Pharm. Pharmacol. 2005; 57: 3–22
   PubMed Web of Science ®Google Scholar
• Ingani H.M., Timmermans J., Moës A. Conception and in vivo investigation of peroral sustained release floating dosage forms with enhanced gastrointestinal transit. J. Int. Pharm. 1987; 35: 157–164
   Web of Science ®Google Scholar
• Mazer N., Abisch E., Gfeller J.-C., Laplanche R., Bauerfeind P., Cucala M., Lukachich M., Blum A. Intragastric behavior and absorption kinetics of a normal and “floating” modified-release capsule of isradipine under fasted and fed conditions. J. Pharm. Sci. 1988; 77: 647–657
   PubMed Web of Science ®Google Scholar
• Washington N., Wilson C.G., Greaves J.L., Danneskiold-Samsøe P. An investigation into the floating behaviour of a pectin-containing anti-reflux formulation (FF5005) by means of gamma scintigraphy, Scand. J. Gastroenterol. 1988; 23: 920–924
   Web of Science ®Google Scholar
• Timmermans J., Van Gansbeke B., Moës A.J. Assessing by gamma scintigraphy the in vivo buoyancy of dosage forms having known size and floating force profiles as a function of time. Congr. Int. Technol. Pharm. 5th. 1989; 1: 42–51
   Google Scholar
• Timmermans J., Moës A.J. Factors controlling the buoyancy and gastric retention capabilities of floating matrix capsules: New data for reconsidering the controversy. J. Pharm. Sci. 1994; 83(1)18–24
   PubMed Web of Science ®Google Scholar
• Babu V.B.M., Khar R.K. In vitro and in vivo studies of sustained-release floating dosage forms containing salbutamol sulfate. Pharmazie 1990; 45: 268–270
   PubMed Web of Science ®Google Scholar
• Phuapradit W., Bolton S. The influence of tablet density on the human oral absorption of sustained release acetaminophen tablets. Drug Dev. Ind. Pharm. 1991; 17: 1097–1107
   Web of Science ®Google Scholar
• Xu W.L., Tu X.D., Lu Z.D. Development of gentamicin sulfate sustained-release tablet floating in stomach. Yaoxue Xuebao 1991; 26(7)541–545
   Google Scholar
• Agyilirah G.A., Green M., DuCret R., Banker G.S. Evaluation of the gastric retention properties of a crosslinked polymer coated tablet versus those of a nondisintegrating tablet. Int. J. Pharm. 1991; 75(2–3)241–247
   Google Scholar
• Hilton A.K., Deasy P.B. In vitro and in vivo evaluation of an oral sustained-release floating dosage form of amoxicillin trihydrate. Int. J. Pharm. 1992; 86: 79–88
   Web of Science ®Google Scholar
• Oth M., Franz M., Timmermans J., Möes A. The bilayer floating capsule: A stomach-directed drug delivery system for misoprostol. Pharm. Res. 1992; 9: 298–302
   PubMed Web of Science ®Google Scholar
• Desai S., Bolton S. A floating controlled-release drug delivery system: In vitro-in vivo evaluation. Pharm. Res. 1993; 10: 1321
   PubMed Web of Science ®Google Scholar
• Özdemir N., Ordu S., Özkan Y. Studies of floating dosage forms of furosemide: in vitro and in vivo evaluations of bilayer tablet formulations. Drug Dev. Ind. Pharm. 2000; 26: 857–866
   PubMed Web of Science ®Google Scholar
• Gabr K.E., Borg T.M. Formulation and evaluation of buffered floating furosemide delivery systems. S.T.P. Pharm. Sci. 2000; 10: 181–186
   Google Scholar
• Chavanpatil M., Jain P., Chaudhari S., Shear R., Vavia P. Development of sustained release gastroretentive drug delivery system for ofloxain: in vitro and in vivo evaluation. Int. J. Pharm. 2005; 304: 178–184
   PubMed Web of Science ®Google Scholar
• Bechgaard H. Distribution of different types of dosage forms in the gastrointestinal tract. Top. Pharm. Sci. 1983; 217–228
   Google Scholar
• Bechgaard H., Christensen F.N., Davis S.S., Hardy J.G., Taylor M.J., Whalley D.R., Wilson C.G. Gastrointestinal transit of pellet systems in ileostomy subjects and the effect of density. J. Pharm. Pharmacol. 1985; 37: 718–721
   PubMed Web of Science ®Google Scholar
• Lippold B.C., Günther J. In-vivo Prüfung einer multipartikulären Retard-Schwimmarzneiform. Eur. J. Pharm. Biopharm. 1991; 37: 254–261
   Web of Science ®Google Scholar
• Kawashima Y., Niwa T., Takeuchi H., Hino T., Ito Y. Preparation of multiple unit hollow microspheres (microballoons) with acrylic resin containing tranilast and their drug release characteristics (in vitro) and floating behavior (in vivo). J. Control. Release 1991; 16: 279–190
   Web of Science ®Google Scholar
• Atyabi F., Sharma H.L., Mohammad H.A.H., Fell J.T. In vivo evaluation of a novel gastric retentive formulation based on ion exchange resins. J. Control. Release 1996; 42: 105–113
   Web of Science ®Google Scholar
• Iannuccelli V., Coppi G., Cameroni R. Intragastric behaviour of a multiple-unit dosage form. Proc. Intl. Symp. Control. Release Bioact. Mater. 1997; 24: 403–404
   Google Scholar
• Iannuccelli V., Coppi G., Sansone R., Ferolla G. Air compartment multiple-unit system for prolonged gastric residence. II. In vivo evaluation. Int. J. Pharm. 1998; 174: 55–62
   Web of Science ®Google Scholar
• Whitehead L., Fell J.T., Collett J.H., Sharma H.L., Smith A.-M. Floating dosage forms: an in vivo study demonstrating prolonged gastric retention. J. Control. Release 1998; 55: 3–12
   PubMed Web of Science ®Google Scholar
• Sawicki W. Pharmacokinetics of verapamil and norverapamil from controlled release floating pellets in humans. Eur. J. Pharm. Biopharm. 2002; 53: 29–35
   PubMed Web of Science ®Google Scholar
• hrrp://www.aapspharmscitech.org, Shimpi, S., Chauhan, B., Mahadik, K.R., Paradkar, A. Preparation and evaluation of diltiazem hydrochloride-gelucire 43/01 floating granules prepared by melt granulation. AAPS PharmSciTech 2004, 5, article 43
   Google Scholar
• Munk J., Gannaway R., Hoare M., Johnson A. H.L. DuthieGastroinestinal Motility in Health and Disease, . MTP, Lancaster 1978; 349–359
   Google Scholar
• Channer K.S., Virjee J.P. The effect of size and shape of tablets on the esophageal transit. J. Clin. Pharmacol. 1986; 26: 141–146
   PubMed Web of Science ®Google Scholar
• Gusler G., Gorsline J., Levy G., Zhang S.Z., Weston I.E., Naret D., Berner B. Pharmacokinetics of metformin gastric-retentive tablets in healthy volunteers. J. Clin. Pharmacol. 2001; 41: 655–661
   PubMed Web of Science ®Google Scholar
• Gusler G., Berner B. Metformin (GRTM) gastric retentive tablets: GI transit and pharmacokinetics in healthy volunteers. Millenial World Congress of Pharm. Sci, San Francisco 2000; 2–5019
   Google Scholar
• Klausner E.A., Lavy E., Barta M., Cserepes E., Friedman M., Hoffman A. Novel gastroretentive dosage forms: Evaluation of gastroretentivity and its effect on levodopa absorption in humans. Pharm. Res. 2003; 20: 1466–1473
   PubMed Web of Science ®Google Scholar
• Cargill R., Caldwell L.J., Engle K., Fix J.A., Porter P.A., Gardner C.R. Controlled gastric emptying. I. Effects of physical properties on gastric residence times of nondisintegrating geometric shapes in beagle dogs. Pharm. Res. 1988; 5: 533–536
   PubMed Web of Science ®Google Scholar